Modelling estimates of the burden of Respiratory Syncytial virus infection in adults and the elderly in the United Kingdom

BMC Infectious Diseases

Volumn 15, Issue 1, 2015, Pages

  Fleming, Douglas M ^a   Taylor, Robert J ^b   Lustig, Roger L ^b   Schuck Paim, Cynthia ^b   Haguinet, François ^c   Webb, David J ^d   Logie, John ^d   Matias, Gonçalo ^c   Taylor, Sylvia ^c  

^a Sage Analytica ^*  (United Kingdom)

^b SAGE Analytica LLC   (United States)

^c GSK   (Belgium)

^d GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Adults; Elderly; Epidemiology; Hospitalisation; Mortality; Respiratory syncytial virus

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DEATH; DISEASE SURVEILLANCE; HOSPITALIZATION; HUMAN; INFECTION RATE; INFECTION RISK; INFLUENZA; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RISK ASSESSMENT; UNITED KINGDOM; ADOLESCENT; CHRONIC DISEASE; CLINICAL TRIAL; FACTUAL DATABASE; FEMALE; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNOLOGY; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; MORTALITY; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; SEASON; STATISTICAL MODEL; VIROLOGY; YOUNG ADULT;

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; CHRONIC DISEASE; DATABASES, FACTUAL; FEMALE; HOSPITALIZATION; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LINEAR MODELS; MALE; MIDDLE AGED; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; SEASONS; UNITED KINGDOM; YOUNG ADULT;

EID: 84944880371     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-015-1218-z     Document Type: Article

References (30)

1. Hall CB. The burgeoning burden of respiratory syncytial virus among children. Infect Disord Drug Targets. 2012;12:92-7.
2. Fleming DM, Elliot AJ. Lessons from 40 years' surveillance of influenza in England and Wales. Epidemiol Infect. 2008;136:866-75.
3. Fleming DM, Cross KW. Respiratory syncytial virus or influenza? Lancet. 1993;342:1507-10.
4. Han LL, Alexander JP, Anderson LJ. Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J Infect Dis. 1999;179:25-30.
5. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005;352:1749-59.
6. Nicholson KG, Kent J, Hammersley V, Cancio E. Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective, population based study of disease burden. BMJ. 1997;315:1060-4.
7. Fleming DM, Elliot AJ. Respiratory syncytial virus: a sleeping giant? Eur Respir J. 2007;30:1029-31.
8. Falsey AR, McElhaney JE, Beran J, van Essen GA, Duval X, Esen M, et al. Respiratory Syncytial Virus and Other Respiratory Viral Infections in Older Adults With Moderate to Severe Influenza-like Illness. J Infect Dis. 2014;209:1873-81.
9. Cherukuri A, Patton K, Gasser RJ, Zuo F, Woo J, Esser MT, et al. Adults 65 years old and older have reduced numbers of functional memory T cells to respiratory syncytial virus fusion protein. Clin Vaccine Immunol. 2013;20:239-47.
10. Looney RJ, Falsey AR, Walsh E, Campbell D. Effect of aging on cytokine production in response to respiratory syncytial virus infection. J Infect Dis. 2002;185:682-5.
11. Pitman RJ, Melegaro A, Gelb D, Siddiqui MR, Gay NJ, Edmunds WJ. Assessing the burden of influenza and other respiratory infections in England and Wales. J Infect. 2007;54:530-8.
12. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179-86.
13. Simonsen L, Taylor RJ, Young-Xu Y, Haber M, May L, Klugman KP. Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States. MBio. 2011;2:e00309-10.
14. Williams T, van Staa T, Puri S, Eaton S. Recent advances in the utility and use of the General Practice Research Database as an example of a UK Primary Care Data resource. Ther Adv Drug Saf. 2012;3:89-99.
15. Brock A, Griffiths C, Rooney C. The impact of introducing ICD-10 on analysis of respiratory mortality trends in England and Wales. Health Stat Q. 2006;9-17.
16. The Flu Immunisation Programme 2012/13 - Publications - GOV.UK [ https://www.gov.uk/government/publications/the-flu-immunisation-programme-2012-13 ]
17. Taxonomy [ http://www.ons.gov.uk/ons/taxonomy/index.html?nscl=Population+Estimates ]
18. Mook P, Joseph C, Ellis J, Zambon M, Fleming D, Watson J. Surveillance of influenza and other respiratory viruses in the United Kingdom: October 2006 to May 2007. Health Protection Report. 2008;2:23. Published on: 6 June 2008.
19. Hardelid P, Pebody R, Andrews N. Mortality caused by influenza and respiratory syncytial virus by age group in England and Wales 1999-2010. Influenza Other Respi Viruses. 2013;7:35-45.
20. Wu P, Goldstein E, Ho LM, Yang L, Nishiura H, Wu JT, et al. Excess mortality associated with influenza A and B virus in Hong Kong, 1998-2009. J Infect Dis. 2012;206:1862-71.
21. Paget WJ, Balderston C, Casas I, Donker G, Edelman L, Fleming D, et al. Assessing the burden of paediatric influenza in Europe: the European Paediatric Influenza Analysis (EPIA) project. Eur J Pediatr. 2010;169:997-1008.
22. Yu H, Alonso WJ, Feng L, Tan Y, Shu Y, Yang W, et al. Characterization of regional influenza seasonality patterns in China and implications for vaccination strategies: spatio-temporal modeling of surveillance data. PLoS Med. 2013;10, e1001552.
23. Thompson WW, Ridenhour BL, Barile JP, Shay DK. Time-series analyses of count data to estimate the burden of seasonal infectious diseases. Epidemiology. 2012;23:839-42. discussion 843-844.
24. Gay NJ, Andrews NJ, Trotter CL, Edmunds WJ. Estimating deaths due to influenza and respiratory syncytial virus. JAMA. 2003;289:2499. author reply 2500-2502.
25. Yang L, Chiu SS, Chan K-P, Chan K-H, Wong W, Peiris J, et al. Validation of statistical models for estimating hospitalization associated with influenza and other respiratory viruses. PLoS One. 2011;6, e17882.
26. Goldstein E, Cobey S, Takahashi S, Miller JC, Lipsitch M. Predicting the epidemic sizes of influenza A/H1N1, A/H3N2, and B: a statistical method. PLoS Med. 2011;8, e1001051.
27. Zambon MC, Stockton JD, Clewley JP, Fleming DM. Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study. Lancet. 2001;358:1410-6.
28. Zhou H, Thompson WW, Viboud CG, Ringholz CM, Cheng P-Y, Steiner C, et al. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect Dis. 2012;54:1427-36.
29. Widmer K, Zhu Y, Williams JV, Griffin MR, Edwards KM, Talbot HK. Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults. J Infect Dis. 2012;206:56-62.
30. Van Asten L, van den Wijngaard C, van Pelt W, van de Kassteele J, Meijer A, van der Hoek W, et al. Mortality attributable to 9 common infections: significant effect of influenza A, respiratory syncytial virus, influenza B, norovirus, and parainfluenza in elderly persons. J Infect Dis. 2012;206:628-39.